Hydrochlorothiazide Quinapril (Accuretic) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Hydrochlorothiazide Quinapril products are in shortage in Canada (4 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 14, 2026.
A combination of an ACE inhibitor and a diuretic used to treat high blood pressure.
Products affected
4 / 10
In shortage since
Mar 1, 2022
Est. full return
Aug 14, 2026
Reports on file
39
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP QUINAPRIL / HCTZ
25MG
20MG · TABLET · JAMP PHARMA CORPORATION
DIN 02547449 · since Jun 30, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACCURETIC
12.5MG
10MG · TABLET · PFIZER CANADA ULC
DIN 02237367 · since Mar 1, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACCURETIC
12.5MG
20MG · TABLET · PFIZER CANADA ULC
DIN 02237368 · since Mar 1, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACCURETIC
25MG
20MG · TABLET · PFIZER CANADA ULC
DIN 02237369 · since Mar 1, 2022, no end estimate · Disruption of the manufacture of the drug.
Resolved
AURO-QUINAPRIL HCTZ
12.5MG
10MG · TABLET · AURO PHARMA INC
DIN 02473291 · ended Jul 24, 2025 · Demand increase for the drug.
Resolved
AURO-QUINAPRIL HCTZ
12.5MG
10MG · TABLET · AURO PHARMA INC
DIN 02473291 · ended Jul 24, 2025 · Demand increase for the drug.
Resolved
AURO-QUINAPRIL HCTZ
12.5MG
20MG · TABLET · AURO PHARMA INC
DIN 02473305 · ended Jul 24, 2025 · Demand increase for the drug.
Resolved
AURO-QUINAPRIL HCTZ
25MG
20MG · TABLET · AURO PHARMA INC
DIN 02473321 · ended Jul 24, 2025 · Demand increase for the drug.
Resolved
AURO-QUINAPRIL HCTZ
25MG
20MG · TABLET · AURO PHARMA INC
DIN 02473321 · ended Jul 24, 2025 · Demand increase for the drug.
Resolved
APO-QUINAPRIL/HCTZ
12.5MG
20MG · TABLET · APOTEX INC
DIN 02408775 · ended Jul 19, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-QUINAPRIL/HCTZ
12.5MG
10MG · TABLET · APOTEX INC
DIN 02408767 · ended Jul 10, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-QUINAPRIL/HCTZ
25MG
20MG · TABLET · APOTEX INC
DIN 02408783 · ended Jul 10, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 39 reports. All reports are on file with Health Canada.
What's happening
Hydrochlorothiazide Quinapril is currently affected by 4 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, PFIZER CANADA ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Hydrochlorothiazide Quinapril is classified under “ACE INHIBITORS, COMBINATIONS” (ATC C09BA).
Recent changes
No changes recorded yet.
Common questions
What is Hydrochlorothiazide Quinapril used for?
A combination of an ACE inhibitor and a diuretic used to treat high blood pressure.
When will Hydrochlorothiazide Quinapril be back in stock in Canada?
The latest manufacturer estimate is Aug 14, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Hydrochlorothiazide Quinapril in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.